A new study indicates that the Xarelto and Eliquis reversal agent Andexxa restores 82% of patients to excellent or good hemostasis following a major bleeding event caused by the blood…
Tag Archives: Portola Pharmaceuticals
The FDA is calling for clinical trials before it will approve the long-delayed Xarelto and Eliquis reversal agent, AndexXa.
Some doctors are expressing concerns about the safety and efficacy of a proposed reversal agent for the blood thinners Eliquis and Xarelto.
A proposed reversal agent for Xarelto and Eliquis stopped 79% of bleeding events suffered by patients after receiving the drugs, according to the findings of a new study.
A proposed reversal agent for the blood thinners Xarelto and Eliquis suffered a setback this week when the FDA rejected its approval, asking questions about manufacturing and its potential use…
The FDA may soon be asked to approve a reversal agent for the blood thinner Xarelto, which has been linked to uncontrollable bleeding events.
More Top Stories
Reader testimonials highlight the severe tooth damage suffered by many Suboxone users as lawyers pursue product liability lawsuits against the manufacturers.
A Bard PowerPort lawsuit accuses the manufacturers of concealing known defects and complications from patients and the medical community.
Three plaintiffs have been awarded a combined total of more than $1.5 billion after filing Roundup lawsuits over their non-Hodgkin's lymphoma diagnoses.